Skip to content
Activities

Operating disciplines.
Long-horizon ownership.

Quartz Capital holds positions in operating businesses, early-stage technology programmes, and strategic sub-holdings across a number of disciplines and jurisdictions. Specific holdings, structures, and counterparty details are shared with qualified partners under non-disclosure.

01

Medical Devices

An operating position in medical devices, active in Northern Europe.

02

Pharmaceuticals

An early-stage pharmaceutical IP position held through the group, pre-commercial in nature.

03

Defense Protection

Protective-technology programmes in the defensive and humanitarian category. No offensive systems, no munitions, no weapons.

04

Digital Health

A health technology platform held within the group.

05

Energy & Strategic Commodities

Commercial intermediation between qualified supply and European downstream buyers, conducted on a relationship-led basis.

06

Real Estate

Property positions in Northern Europe, held on a long horizon.

07

Retail & Franchise

Franchise operating positions in Northern Europe.

08

Artificial Intelligence

Quartz develops and applies artificial intelligence to real operating problems — diagnostics, decision support, document and signal processing across the group's industries. The work is engineered for measurable outcomes in regulated environments rather than for general novelty.

09

Blockchain Technology

Quartz invests in and develops blockchain infrastructure where it solves a concrete problem of settlement, custody, provenance, or coordination. The posture is sober and infrastructural; speculation is not the thesis.

Further positions

Additional activities held privately

Beyond the disciplines listed above, the group maintains further positions across financial technology, services, and operating businesses in several jurisdictions. These are managed privately and discussed with qualified parties only.

For specifics, we expect a conversation.

We do not publish ownership percentages, valuations, financial details, or counterparty names. Qualified investors, commercial counterparties, and acquisition partners are welcome to inquire directly. Substantive engagement begins under mutual non-disclosure.